These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38756399)

  • 1. 340B Contract pharmacy growth by pharmacy ownership: 2009-2022.
    McGlave C; Bruno JP; Watts E; Nikpay S
    Health Aff Sch; 2024 Jan; 2(1):qxad075. PubMed ID: 38756399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of 340B contract pharmacy growth with county-level characteristics.
    Nikpay S; Gracia G; Geressu H; Conti R
    Am J Manag Care; 2022 Mar; 28(3):133-136. PubMed ID: 35404549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges for Managed Care from 340B Contract Pharmacies.
    Fein AJ
    J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.
    Clark BL; Hou J; Chou CH; Huang ES; Conti R
    Health Aff (Millwood); 2014 Nov; 33(11):2012-7. PubMed ID: 25367997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
    Ruley M; Belcher M; Sayre H; Coustasse A
    Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022.
    Nikpay S; McGlave CC; Bruno JP; Yang H; Watts E
    JAMA Health Forum; 2023 Aug; 4(8):e232139. PubMed ID: 37540525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Income differences between locations of 340B entities and contract pharmacies.
    Masia N; Kuwonza F
    Am J Manag Care; 2023 Jun; 29(6):e184-e188. PubMed ID: 37341983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the Benefits of the 340b Drug Discount Program.
    Gerlach J; McSweeney S; Swearingen A; Coustasse A
    Health Care Manag (Frederick); 2018; 37(3):225-231. PubMed ID: 29901471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of the 340B Drug Pricing Program: A Scoping Review.
    Knox RP; Wang J; Feldman WB; Kesselheim AS; Sarpatwari A
    JAMA Health Forum; 2023 Nov; 4(11):e233716. PubMed ID: 37991784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
    Conti RM; Nikpay SS; Buntin MB
    JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community Health Center 340B Program: A Qualitative Study of the Experiences of Patients with Diabetes.
    Wagner AA; Whitner JB; Williams AC; Hirt KL; Miracle TL; Valentino AS
    Innov Pharm; 2023; 14(3):. PubMed ID: 38487386
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP National Survey of Health-System Specialty Pharmacy Practice-2020.
    Stubbings J; Pedersen CA; Low K; Chen D
    Am J Health Syst Pharm; 2021 Sep; 78(19):1765-1791. PubMed ID: 34345889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of medication access services at 340B and non-340B hospitals.
    Rana I; von Oehsen W; Nabulsi NA; Sharp LK; Donnelly AJ; Shah SD; Stubbings J; Durley SF
    Res Social Adm Pharm; 2021 Nov; 17(11):1887-1892. PubMed ID: 33846100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.
    Luo J; Kulldorff M; Sarpatwari A; Pawar A; Kesselheim AS
    Ann Intern Med; 2019 Nov; 171(9):605-611. PubMed ID: 31569218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Discounted and Undiscounted Cash Prices for Cardiovascular Medications by Type of US Community Pharmacy.
    Hong M; Shcherbakova N
    J Gen Intern Med; 2021 Jan; 36(1):114-120. PubMed ID: 32885368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020.
    Dickson S; Gabriel N; Hernandez I
    JAMA Health Forum; 2023 Nov; 4(11):e234091. PubMed ID: 37976048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis.
    Berenbrok LA; Tang S; Gabriel N; Guo J; Sharareh N; Patel N; Dickson S; Hernandez I
    J Am Pharm Assoc (2003); 2022; 62(6):1816-1822.e2. PubMed ID: 35965233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting bargaining outcomes between pharmacies and insurers.
    Brooks JM; Doucette W; Sorofman B
    Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
    Lee CH; Chang J; McCombs J
    J Manag Care Spec Pharm; 2019 Feb; 25(2):178-187. PubMed ID: 30698090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing pharmacy services based on grocery store patron preferences.
    Lindstrom NS; Casper KA; Green TR; Pedersen CA
    J Am Pharm Assoc (2003); 2007; 47(5):605-12. PubMed ID: 17848350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.